NOX4 Antibody [M9N20] | Primary Antibodies

Application: Reactivity: Human, Mouse, Rat

Usage Information

Dilution
WB1:2000 IHC1:200-500 IF1:100 FCM1:1000

Application
WB, IHC, IF, FCM

Reactivity
Human, Mouse, Rat

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
67 kDa

Datasheet & SDS

Biological Description

Specificity
NOX4 Antibody [M9N20] detects endogenous levels of total NOX4 protein.

Clone
M9N20

Synonym(s)
Kidney oxidase-1, Kidney superoxide-producing NADPH oxidase, KOX-1, KOX1, NADPH oxidase 4, NOX 4, NOX-4, NOX4, NOX4v, Renal NAD(P)H-oxidase, Superoxide-generating NADPH oxidase 4, AI648021, KOX, KOX-1, NOX4, RENOX

Background
NOX4 is a member of the NADPH oxidase family that functions as a constitutively active redox enzyme generating reactive oxygen species, predominantly hydrogen peroxide, and contributes to basal and signal‑regulated redox tone across multiple tissues including kidney, vasculature, and liver. The protein shares the core NOX architecture with multiple transmembrane helices that bind heme groups, a cytosolic dehydrogenase domain that associates with FAD and NADPH, and cytoplasmic loops that participate in electron transfer to molecular oxygen, but unlike NOX1 and NOX2, it does not require the classic cytosolic NOX organizer and activator subunits or Rac GTPase for its activity. NOX4 produces hydrogen peroxide at relatively high constitutive rates, and its activity is regulated primarily at the level of expression and subcellular localization rather than rapid assembly of multi‑subunit complexes, which makes it a source of steady‑state ROS for signaling rather than short oxidative bursts. In cardiovascular and renal systems, NOX4 localizes to intracellular membranes including endoplasmic reticulum, nucleus, and mitochondria‑associated regions, and the hydrogen peroxide it generates modulates redox‑sensitive targets such as protein tyrosine phosphatases, kinases, and transcription factors, influencing pathways linked to cell growth, differentiation, apoptosis, and hypoxic responses. NOX4 expression is controlled by transcription factors downstream of TGF‑β and hypoxia pathways, including Smad complexes and HIF family members, and these regulatory links place NOX4 in circuits that couple profibrotic growth factor signaling and oxygen availability to changes in redox signaling and gene expression profiles. In cardiac and vascular cells, NOX4‑derived ROS participate in differentiation programs and adaptive remodeling, including cardiac lineage specification and angiogenic responses, where controlled NOX4 activity contributes to mitochondrial biogenesis, cytoskeletal organization, and modulation of contractile and matrix genes. Across malignancies, NOX4 is widely expressed and connects redox signaling to tumor cell metabolism, survival, and interaction with the microenvironment; NOX4 activity can support oncogenic pathways by sustaining proliferative and migratory signaling, but in specific contexts such as hepatocellular carcinoma NOX4 expression associates with tumor‑suppressive functions, reduced proliferation, and altered metabolic and redox homeostasis. These context‑dependent effects reflect the ability of NOX4‑derived hydrogen peroxide to regulate both pro‑survival and pro‑apoptotic signaling nodes, and they make NOX4 a bidirectional modulator whose impact depends on expression level, localization, and the surrounding signaling network.

Background

NOX4 is a member of the NADPH oxidase family that functions as a constitutively active redox enzyme generating reactive oxygen species, predominantly hydrogen peroxide, and contributes to basal and signal‑regulated redox tone across multiple tissues including kidney, vasculature, and liver. The protein shares the core NOX architecture with multiple transmembrane helices that bind heme groups, a cytosolic dehydrogenase domain that associates with FAD and NADPH, and cytoplasmic loops that participate in electron transfer to molecular oxygen, but unlike NOX1 and NOX2, it does not require the classic cytosolic NOX organizer and activator subunits or Rac GTPase for its activity. NOX4 produces hydrogen peroxide at relatively high constitutive rates, and its activity is regulated primarily at the level of expression and subcellular localization rather than rapid assembly of multi‑subunit complexes, which makes it a source of steady‑state ROS for signaling rather than short oxidative bursts. In cardiovascular and renal systems, NOX4 localizes to intracellular membranes including endoplasmic reticulum, nucleus, and mitochondria‑associated regions, and the hydrogen peroxide it generates modulates redox‑sensitive targets such as protein tyrosine phosphatases, kinases, and transcription factors, influencing pathways linked to cell growth, differentiation, apoptosis, and hypoxic responses. NOX4 expression is controlled by transcription factors downstream of TGF‑β and hypoxia pathways, including Smad complexes and HIF family members, and these regulatory links place NOX4 in circuits that couple profibrotic growth factor signaling and oxygen availability to changes in redox signaling and gene expression profiles. In cardiac and vascular cells, NOX4‑derived ROS participate in differentiation programs and adaptive remodeling, including cardiac lineage specification and angiogenic responses, where controlled NOX4 activity contributes to mitochondrial biogenesis, cytoskeletal organization, and modulation of contractile and matrix genes. Across malignancies, NOX4 is widely expressed and connects redox signaling to tumor cell metabolism, survival, and interaction with the microenvironment; NOX4 activity can support oncogenic pathways by sustaining proliferative and migratory signaling, but in specific contexts such as hepatocellular carcinoma NOX4 expression associates with tumor‑suppressive functions, reduced proliferation, and altered metabolic and redox homeostasis. These context‑dependent effects reflect the ability of NOX4‑derived hydrogen peroxide to regulate both pro‑survival and pro‑apoptotic signaling nodes, and they make NOX4 a bidirectional modulator whose impact depends on expression level, localization, and the surrounding signaling network.

References
https://pubmed.ncbi.nlm.nih.gov/35269843/ https://pubmed.ncbi.nlm.nih.gov/25062272/

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%